http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011288402-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6023659f0ef9eacc7d46583fa828c3ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7317808024e524eea40a6c5a5ad6a22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e61c05e77c17222eb8d68a123c31458
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_16958655646356066208c3032d7987fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d83794ab557737933556d644294d98a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7cd41e3623efe6bf5b7130651f653295
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6e88ada956151edaf69855a9cbb9fed
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-5601
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-5616
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-055
filingDate 2009-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa5f15012de2531e8922f3463508eca6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05ec30e9a698d405167242de00e77a5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_029044f53dd9213b333f13abe6f782c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c09b21cf070193b0dffe5b90c395d41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ba4eaa509623ee2d64a17c680dcd06e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49c8424959981abb2e862190c401ae7c
publicationDate 2011-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2011288402-A1
titleOfInvention Mr imaging with cest contrast enhancement
abstract The invention relates to a method of MR imaging of at least a portion of a body of a patient placed in an examination volume of an MR device. The object of the invention is to improve CEST contrast enhanced imaging. The method of the invention comprises the following steps: a) saturation of nuclear magnetization of exchangeable protons of a CEST contrast agent administered to the patient by subjecting the portion of the body to at least one frequency-selective saturation RF pulse matched to the MR frequency of exchangeable protons of the CEST contrast agent, wherein the saturation period, i.e. the duration of the frequency-selective saturation RF pulse, is shorter than the time required for saturation to build up a full CEST contrast enhancement effect when starting from zero saturation; b) generating at least one MR signal of water protons of the body by subjecting the portion of the body to an MR imaging sequence comprising at least one RF pulse and switched magnetic field gradients; c) acquiring sampling the at least one MR signal from the body; d) repeating steps a) to c) a number of times under variation of parameters of the MR imaging sequence, wherein MR signals are acquired and sampled during a saturation build-up period, i.e. before a steady state of the CEST effect is achieved; e) reconstructing a proton-density weighted, CEST contrast-enhanced MR image from the acquired and sampled MR signals.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101729811-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE44644-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015051474-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9354288-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015077110-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE45725-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10175332-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10234527-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9766313-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE47178-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE48347-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014039297-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015134934-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108051765-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9599691-B2
priorityDate 2008-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008188738-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010026297-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010254913-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7999546-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7917188-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009142273-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450540594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158536
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449030523
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635

Total number of triples: 50.